Navigation Links
PulmoBioTech Announces Details of Its Regulatory Approval Experiments
Date:4/24/2008

NEW YORK, April 24 /PRNewswire-FirstCall/ -- PulmoBioTech Inc. (OTC Bulletin Board: PLMO) announced today that its PulmoScience subsidiary has released details of the areas that it will be investigating as part of the Regulatory Approval Experiments for Human Trials. The areas are:

1. Efficacy Binding Studies

2. Characterization of Drug Product Impurities

3. Sterility Studies

4. Pyrogenicity

5. Immunological Testing

6. Dosimetry

7. Toxicity

PulmoScience will be completing all the relevant tests in each area and seeking Regulatory sign-off before starting the detailed Human Trials. This is currently expected to be achieved in the first half of 2008.

About PulmoBioTech Inc.

PulmoBioTech Inc. specializes in the development and marketing of medical technology and research. Our proven strengths combine extensive commercial experience and academic credentials. The principal staff members are acknowledged experts in their specialized field, and work with a broad range of investment institutions. PulmoBioTech's mission is to utilize scientific imagination and drive, together with managerial and financial acumen, to bring innovative and profitable products to the marketplace to the benefit of all stock holders.

About PulmoScience Inc.

PulmoScience Inc. was established in 2006, and is currently developing a non-invasive Molecular Imaging technique for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory diseases under the trade name PulmoBind.

The company was conceived within the Montreal Heart Institute "MHI" (a world renowned hospital and educational facility). Jointly owned by MHI subsidiary Innovacor as the technical and operational partner, Dr. Jocelyn Dupuis (the scientific director and originator of the PulmoBind Molecular Imaging technology), and by PulmoBioTech Inc. as the funding partner, PulmoScience Inc. aims to develop this unique and ex
'/>"/>

SOURCE PulmoBioTech Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... , March 27, 2015 Biopharmaceutical Industry ... biopharmaceutical industry comes out on top as the country,s ... new report  from ndp│analytics. According to the  analysis ... (R&D) investment over the last decade, accounting for 27 ... A Short Video on Medicare Part ...
(Date:3/27/2015)... 2015 The Temple Health & Bioscience District (THBD) ... building at 1802 South First St. in the Temple Medical ... City of Temple to receive funding ... Central Texas Veterans Health Care System, the new facility will ... stage biotechnology and life science companies. ...
(Date:3/27/2015)... A new report from Kalorama Information says that other countries ... Chile , Colombia and ... The healthcare research firm said that while Brazil ... American continent with a population of over 200 million people ... country,s regional economic clout does not necessarily ensure its status ...
Breaking Medicine Technology:Week in Review: The Latest from PhRMA 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 2Kalorama: Beyond Brazil, Latin American IVD Market Grows 3Kalorama: Beyond Brazil, Latin American IVD Market Grows 4
... SHELTON, Connecticut, October 25, 2011 ...   (NASDAQ OMX Stockholm: SECT B) ... Agreement with University Hospitals (UH) in Cleveland.   ... enhancements in medical imaging with the goals of improving ...
... Misonix, Inc. (NASDAQ: MSON ), ... markets innovative therapeutic ultrasonic products worldwide for wound ... and other surgical and medical applications, has announced ... Cutting System at the International Meeting on Advanced ...
Cached Medicine Technology:Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland 2Sectra Signs Medical Imaging Research Agreement With University Hospitals in Cleveland 3Misonix Exhibits BoneScalpel™ at the International Meeting on Advanced Spine Techniques 2Misonix Exhibits BoneScalpel™ at the International Meeting on Advanced Spine Techniques 3
(Date:3/29/2015)... Adults who are comparing the different types of ... can now use the QuotesPros.com website for assistance. New ... explored while researching the automated database now in place ... what a term policy provides and what a permanent ... and women. Insurers typically provide base pricing for length ...
(Date:3/29/2015)... The federal court overseeing hundreds ... in the U.S. District Court, Northern District of ... Conference for April 21st at 1:30 p.m. Court ... progress of product liability claims filed on behalf ... and other cardiovascular complications due to their use ...
(Date:3/29/2015)... “Health is an endo thing, from within,” ... about the cannabinoid system … we learn it’s where ... Endo-Cannabinoid Update ~ new on the Bryan William ... of The Cannabis Papers: A citizen’s guide to cannabinoids ... cannabinoid system (CS) articles discussing: cannabinoids in the treatment ...
(Date:3/28/2015)... Take a bite of warm, gooey pepperoni ... tumble into the stomach, ready to break down your ... these acids run amok, triggering a burning sensation in ... than 60 million Americans have heartburn at least once ... and how it can be stopped. , Heartburn or ...
(Date:3/28/2015)... India Network visitor health insurance announced ... visitors who purchase the plan before arrival in the ... purchase the insurance program as soon as travel plans ... pre-existing medical conditions. Parents and grandparents traveling from India ... serious consequences to their health. Many visitors may not ...
Breaking Medicine News(10 mins):Health News:Permanent Life Insurance Quotes Now Offered Through Web Search System at Insurer Website Online 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 2Health News:Federal Court Overseeing Testosterone Treatment Lawsuits Schedules April Case Management Conference 3Health News:March Homeostasis: Publius’ Go Endo-Cannabinoid Update ~ New on the Bryan William Brickner Blog 2Health News:Bypass Your Heartburn Worries This Easter With Tylers Coffee 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 2Health News:India Network Health Insurance Today Announces New Eligibility Criteria for Pre-existing Condition Health Insurance Coverage for Visitors to the United States 3
... reported vector-borne disease in the United States, with the majority ... decades since the agent of the disease, the spirochete ... identified. However, the number of Lyme disease cases have steadily ... issuue of the Journal of Medical Entomology called ...
... Reporter , WEDNESDAY, Jan. 4 (HealthDay News) -- Some people ... chemotherapy, and a mutation in the so-called TFAP2E gene may ... Knowing which patients carry the mutation might help ... researchers said. "In our study, we identified a gene ...
... HealthDay Reporter , WEDNESDAY, Jan. 4 (HealthDay News) -- Small ... States in recent years are charted in a new report. ... 1.8 percent a year in men and 1.6 percent a year ... from 1990 through 2008, death rates plunged almost 23 percent for ...
... When patients with diabetes experience interruptions in health - insurance ... and vaccines they need to protect their health. A new ... free or reduced-cost medical care at federally funded safety net ... National Institutes of Health and findings published online in the ...
... Reporter , WEDNESDAY, Jan. 4 (HealthDay News) -- Remember ... steep, but you took the plunge and whizzed downward. ... higher and hanging by your knees at the pinnacle. ... Low sliding boards, safer plastic climbers and fence-protected platforms ...
... Remick, M.D. lead investigators at the Los Angeles ... are spearheading a statewide, web-based survey scheduled to ... the pediatric emergency readiness of hospital emergency departments (EDs). ... this project also represents an enormous quality improvement initiative ...
Cached Medicine News:Health News:How can Lyme disease be prevented and controlled? 2Health News:Gene Mutation Linked to Chemo-Resistant Colon Cancer 2Health News:Cancer Incidence, Death Rates Continue to Drop: Report 2Health News:Cancer Incidence, Death Rates Continue to Drop: Report 3Health News:Kaiser Permanente study finds continuous health coverage essential for patients managing diabetes 2Health News:'Safety-First' Playgrounds Linked to Bored, Inactive Kids: Study 2Health News:'Safety-First' Playgrounds Linked to Bored, Inactive Kids: Study 3Health News:LA BioMed investigators lead first survey to determine hospital EDs' pediatric readiness 2
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... pouches are designed for individual application and ... used in nursing homes, home healthcare settings, ... other hospital departments. This unit dose pouch ... antiseptic, germicidal and cleansing agent. Hydrogen Peroxide's ...
... Aplicare's Iodine Scrub is a gentle ... formulated to prevent dryness. Povidone Iodine is ... gram-negative and gram-positive bacteria, fungi, viruses, protozoa ... lather; the first step in patient pre-operative ...
... is appropriate for pre-surgical patient preparation ... spray); disinfecting of wounds and burns; ... and abrasions. It also acts as ... and office procedures, providing protection against ...
Medicine Products: